Our initial aim was to explore the expression of pro-tumour ADP-ribosyltransferases PARP14 and PARP9/DTX3L particularly in HNSCC, which are characteristically resistant to treatment and PARP9/14 mediated survival might represent a mechanism for increased survival. The gene discussed is DTX3L; the disease is head and neck squamous cell carcinoma.